Biocept inc stock split
BIOC Price Target and Analyst Ratings (Biocept) | MarketBeat Nov 07, 2019 · 1 Wall Street analysts have issued ratings and price targets for Biocept in the last 12 months. Their average twelve-month price target is $1.00, suggesting that the stock has a possible upside of 254.61%. The high price target for BIOC is $1.00 and the low price target for BIOC is $1.00. Biocept (BIOC) Stock: Soaring On Positive PR | CNA Finance Jan 10, 2017 · Biocept Inc (NASDAQ: BIOC). Biocept is having an overwhelmingly strong start to the trading session today. When the opening bell rang, the stock … BIOC: Biocept, Inc. - Full Company Report - Zacks.com Get the latest Full Company Report for Biocept, Inc. from Zacks Investment Research every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making Form S-3 BIOCEPT INC - StreetInsider.com
Apr 01, 2020 · Shares of Biocept Inc. (BIOC) plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock offering at a deep discount.The company said it agreed on the issuance and sale of 23 million shares of common stock to several institutional investors, which would increase the shares outstanding by about 54%, according …
Biocept - Stock Split History | BIOC | MacroTrends 35 rows · Stock split history for Biocept since 2020. Prices shown are actual historical values and are … Biocept, Inc. Common Stock (BIOC) Stock Quotes | Nasdaq Biocept, Inc. Common Stock (BIOC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Biocept, Inc. Common Stock (BIOC) Historical Data | Nasdaq
Mar 25, 2020 · The per-share figures reflect a 1-for-30 reverse split of common stock completed in July 2018. Biocept reported cash and cash equivalents as of December 31, 2019 of $9.3 million, compared with $3.4 million as of December 31, 2018.
BIOCEPT, INC. - REVERSE SPLIT OPTION SYMBOL: BIOC NEW ... Biocept, Inc. (BIOC) has announced a 1-for-3 reverse stock split. As a result of the reverse stock split, each BIOC Common Share will be converted into the right to receive approximately 0.333333 (New) Biocept, Inc. Common Shares. Fractional BIOC shares will be rounded up to the next whole share. The reverse stock split will become effective Biocept Announces Pricing of $15.0 Million Public Offering ... Biocept Announces Pricing of $15.0 Million Public Offering of 33,333,333 Shares of Common Stock and Warrants to Purchase 33,333,333 Shares of Common Stock News provided by Biocept, Inc. BIOC | Biocept Inc. Insider Actions | MarketWatch Nov 06, 2019 · Biocept Inc. insider activity by MarketWatch. View the latest news on BIOC company insiders for best stock investing positioning.
Biocept Inc. Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.
Investment Calculator | Biocept Inc.
BIOC / Biocept, Inc. Overview - (09072V105) - Stock ...
Biocept, Inc. (BIOC) Split History | Seeking Alpha See Biocept, Inc. (BIOC) history of stock splits. Includes date and ratio. BIOC Stock Price, Forecast & News (Biocept) | MarketBeat Biocept's stock was trading at $0.3769 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BIOC stock has decreased by 28.2% and is now trading at $0.2706. View which stocks have been mosted impacted by Coronavirus. BIOC | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for BIOCEPT INC (BIOC), including profile, stock chart, recent news and events, analyst opinions, and research reports.
BIOC - Biocept Stock Profile - Barchart.com Biocept Inc (BIOC) [[ item.lastPrice ]] A stock's Profile page contains general information about the stock, such as Ticker Symbol, Exchange traded on, Company Contact Address/Phone, CEO/President, and Company Description. Most Recent Split: The share split recorded and … BIOC - Research and Analysis for BIOCEPT, INC. - MSN Money. In-depth view of key statistics and finances for BIOCEPT, INC. (BIOC) on MSN Money. BIOCEPT, INC. (NASDAQ:BIOC) Files An 8-K Material ...